Patient-Reported AutoImmunity Secondary to Cancer immunothErapy

Clinical trial NCT03849131 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03849131
Sponsor: University Hospital, Strasbourg, France
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Opportunistic Autoimmune Diseases

Start date: 2019-11-29
Primary completion: 2025-06-01
Enrollment: 905

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.